Document Detail

Thrombolytic therapy within one hour of the onset of acute myocardial infarction.
MedLine Citation:
PMID:  1946929     Owner:  NLM     Status:  MEDLINE    
Between 1986 and 1988, 239 consecutive patients with acute myocardial infarction received thrombolytic therapy up to 285 minutes after onset of symptoms; in 39 (17 with anterior infarction, 21 inferior, one lateral infarction) recombinant tissue plasminogen activator or anistreplase was administered a mean of 51 minutes (range 20-60 minutes) after the onset of symptoms. The patency rates (26 of 30; 87 per cent), rapid ST segment resolution (36 of 38; 95 per cent) and QRS score of less than or equal to 3 (28 of 38; 74 per cent) were statistically significantly higher for those seen and treated in the first hour in comparison with those seen and treated later. For those treated within the first hour mean peak creatine kinase was 1264 U/l for those with TIMI grade 2 or 3 (partial or complete perfusion) compared with 3005 U/l for those with TIMI grade 0 or 1 (no perfusion or penetration without perfusion) (p = 0.02): mean peak creatine kinase-MB for those with TIMI grade 2 or 3 perfusion was 115 U/l compared with 312 U/l for those with TIMI grade 0 or 1 (p = 0.01). Four of the 39 patients developed ventricular fibrillation following thrombolytic therapy, three within 24 hours of infarction and one following reinfarction on day 15. There were no significant bleeding complications. One patient died. Thrombolytic therapy within 1 hour of the onset of symptoms led to a very high angiographic patency rate, rapid ST segment resolution with preservation of left ventricular function. This therapy is without significant complications.
A J McNeill; D J Flannery; C M Wilson; G W Dalzell; N P Campbell; M M Khan; G C Patterson; S W Webb; A A Adgey
Related Documents :
6222849 - Methodologic aspects of intracoronary thrombolysis. drugs, dosage and duration.
2662739 - Comparison of thrombolytic agents: selected hematologic, vascular and clinical events.
6969559 - Corticosteroids in acute myocardial infarction.
10545429 - Platelet function during and after thrombolytic therapy for acute myocardial infarction...
14988779 - Thrombolytic therapy in acute myocardial infarction.
7605149 - Epidemiology of avoidable delay in the care of patients with acute myocardial infarctio...
19436789 - Cardiac tamponade as a sequela to ventriculoatrial shunting for congenital hydrocephalus.
7867179 - Coronary stenting decreases restenosis in lesions with early loss in luminal diameter 2...
8595059 - Comparison of the cardioprotective efficacy of superoxide dismutase in a single and a r...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The Quarterly journal of medicine     Volume:  79     ISSN:  0033-5622     ISO Abbreviation:  Q. J. Med.     Publication Date:  1991 Jun 
Date Detail:
Created Date:  1991-11-27     Completed Date:  1991-11-27     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0401027     Medline TA:  Q J Med     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  487-94     Citation Subset:  IM    
Regional Medical Cardiology Centre, Royal Victoria Hospital, Belfast.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anistreplase / administration & dosage*
Creatine Kinase / blood
Drug Administration Schedule
Heart / physiopathology
Myocardial Infarction / drug therapy*,  enzymology,  physiopathology
Prospective Studies
Recombinant Proteins / administration & dosage
Thrombolytic Therapy / methods*
Tissue Plasminogen Activator / administration & dosage*
Reg. No./Substance:
0/Isoenzymes; 0/Recombinant Proteins; 81669-57-0/Anistreplase; EC Kinase; EC Plasminogen Activator

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Polycystic kidney disease re-evaluated: a population-based study.
Next Document:  The influence of autonomic neuropathy on mortality in insulin-dependent diabetes.